Ganglioside

This page covers all Ganglioside drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Growth factor receptors; neuronal cell surface ganglioside receptors, Growth factor receptors (indirect); neuronal cell surface ganglioside.

Targets

Growth factor receptors; neuronal cell surface ganglioside receptors · Growth factor receptors (indirect); neuronal cell surface ganglioside

Marketed (1)

• Monosialoganglioside GM1 · General Hospital of Shenyang Military Region · Neurology
  Monosialoganglioside GM1 is a ganglioside that promotes neuronal repair and regeneration by enhancing neurite outgrowth and protecting neurons from damage.

Phase 3 pipeline (1)

• GM1 · Qilu Pharmaceutical Co., Ltd. · Neurology
  GM1 is a monosialotetrahexosylganglioside that promotes neuronal protection and regeneration by enhancing nerve growth factor signaling and reducing neuroinflammation.